Poly Medicure Limited

NSE:POLYMED.NS

2502.85 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32012 Q42012 Q32012 Q22012 Q1
Revenue 3,847.7643,780.7423,395.9823,372.9393,208.33,068.5262,848.2932,746.9532,488.5322,513.0462,302.7552,233.6822,119.3962,015.2382,035.1011,996.2541,703.761,533.5271,804.3991,738.8161,615.8741,641.8831,487.0251,501.7541,336.6011,392.7451,257.469759.258612.46612.852565.871
Cost of Revenue 2,186.9892,168.4871,180.4311,212.0851,121.5191,048.4461,025.0741,059.132926.11,869.659908.454834.509718.8331,499.482678.926602.331583.8881,230.734579.54537.118509.0541,328.461529.903480.666407.7991,123.539384.935524.153202.245212.013191.831
Gross Profit 1,660.7751,612.2552,215.5512,160.8542,086.7812,020.081,823.2191,687.8211,562.432643.3871,394.3011,399.1731,400.563515.7561,356.1751,393.9231,119.872302.7931,224.8591,201.6981,106.82313.422957.1221,021.088928.802269.206872.534235.105410.215400.839374.04
Gross Profit Ratio 0.4320.4260.6520.6410.650.6580.640.6140.6280.2560.6050.6260.6610.2560.6660.6980.6570.1970.6790.6910.6850.1910.6440.680.6950.1930.6940.310.670.6540.661
Reseach & Development Expenses 41.20549.04247.08450.62442.85357.72741.6839.39539.22351.11847.94849.98638.65937.74232.74131.10929.85334.828.02328.41428.18712.53229.15130.47329.33427.17723.8950000
General & Administrative Expenses 00000566.572000474.273000397.508000365.687000343.05200000-547.65163.880202.218
Selling & Marketing Expenses 0000028.51400012.8910008.02200026.5300035.462000000000
SG&A 776.907759.418662.239684.757577.455595.086537.971496.691454.051487.164419.64390.548434.47405.53373.584366.041302.628392.217348.587359.018331.606378.514297.854279.166268.82900-469.473163.880202.218
Other Expenses 169.191149.73165.676140.926131.14984.945144.30686.89345.71-261.23171.352122.592102.747-105.19550.43832.34634.67-123.62540.35650.21641.758-83.34537.47641.11133.34-88.58335.468413.512111.642340.523109.775
Operating Expenses 818.112808.461,475.4621,478.4741,370.0941,335.8341,254.9551,183.4881,237.095176.0861,018.3541,025.453975.93965.092903.726943.132771.115-40.444877.355885.775842.60244.29740.106769.573706.569-0.092647.548-69.54275.522340.523311.993
Operating Income 842.663803.795912.902831.659716.687775.048716.178597.047325.337421.955375.947373.72424.624450.664452.449450.791348.757343.237347.504315.923264.218269.132217.016251.515222.233269.298224.986132.275134.69360.31662.047
Operating Income Ratio 0.2190.2130.2690.2470.2230.2530.2510.2170.1310.1680.1630.1670.20.2240.2220.2260.2050.2240.1930.1820.1640.1640.1460.1670.1660.1930.1790.1740.220.0980.11
Total Other Income Expenses Net 137.571118.484-34.656-22.189113.72-23.487-48.253-4.53137.57665.9682.446130.48377.31467.5067.7468.9313.677-54.311-11.21738.84413.03516.63646.125-19.681-3.555-0.04117.854-5.615-18.825-14.558-19.822
Income Before Tax 980.234922.279878.246809.47830.407751.561667.925592.516362.913487.915458.393504.203501.938518.17460.195459.721362.434288.926336.287354.767277.253285.768263.141231.834218.678269.257242.84126.66115.86845.75842.225
Income Before Tax Ratio 0.2550.2440.2590.240.2590.2450.2350.2160.1460.1940.1990.2260.2370.2570.2260.230.2130.1880.1860.2040.1720.1740.1770.1540.1640.1930.1930.1670.1890.0750.075
Income Tax Expense 244.179240.989228.087187.58203.451163.453167.823157.52393.29126.252113.28121.855126.002129.706107.115109.62795.34862.37386.11770.76479.279.78694.81586.20585.9534.74477.48441.66333.41910.92211.754
Net Income 740.394683.579650.159621.89626.956588.108500.102434.993269.623361.663345.113382.348375.936388.464353.08350.094267.106226.553250.17284.003198.053205.982168.326145.629132.728234.513165.35694.54382.44934.83630.471
Net Income Ratio 0.1920.1810.1910.1840.1950.1920.1760.1580.1080.1440.150.1710.1770.1930.1730.1750.1570.1480.1390.1630.1230.1250.1130.0970.0990.1680.1310.1250.1350.0570.054
EPS 7.717.356.786.486.536.135.214.542.813.773.63.993.924.443.973.032.572.833.222.242.341.821.651.52.661.891.070.940.40.35
EPS Diluted 7.717.356.776.476.536.135.24.532.813.773.63.983.924.43.993.963.032.572.833.222.242.341.821.651.52.661.891.070.940.40.35
EBITDA 1,039.16965.7951,075.016991.5621,010.574922.924858.112739.558514.375636.975511.895641.12662.585617.58633.606601.817500.12461.479498.411473.046409.608405.991310.605389.548345.913386.911331.237170.284165.71589.42690.151
EBITDA Ratio 0.270.2550.3170.2940.3150.3010.3010.2690.2070.2530.2220.2870.3130.3060.3110.3010.2940.3010.2760.2720.2530.2470.2090.2590.2590.2780.2630.2240.2710.1460.159